Christopher J. Kirk - Nov 8, 2023 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
CEO, Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Nov 8, 2023
Transactions value $
$0
Form type
4
Date filed
11/9/2023, 04:25 PM
Previous filing
Jul 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +875K $0.00 875K Nov 8, 2023 Common Stock 875K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on December 7, 2023, subject to the Reporting Person continuing to provide service through each such date.